SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to market volatility sparked by uncertainty surrounding the ongoing military conflict with Iran, with participants actively debating the company's fundamentals against the backdrop of broader geopolitical instability. The discussion on social platforms is highly polarized, focusing on skepticism regarding official administration announcements, concerns over economic repercussions, and intense commentary on leadership credibility.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing a significant sell-off as investors react to two consecutive legal losses in California regarding addictive design, with community members fiercely debating whether to blame the platform's algorithms or personal responsibility. While some traders are expressing extreme bearish sentiment and fear that these rulings create a precedent for thousands of future lawsuits, others view the sharp pullback as a buying opportunity, emphasizing that the company's underlying fundamentals and revenue generation remain intact.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing heightened volatility and investor scrutiny as the stock faces continued selling pressure, with community sentiment split between those viewing the current valuation as a deep-value buying opportunity and others concerned by broader sector headwinds. Investors are actively debating the company's long-term pivot toward its 'Grow' and advertising segments while keeping a close watch on potential catalysts like upcoming product demos and rumors surrounding the sale of the Unity China division.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending as investors digest a wave of positive analyst upgrades and persistent M&A speculation, with the community actively debating whether the stock's long-term potential as the first-to-market MASH treatment justifies current valuations. While sentiment remains divided between those expecting a near-term buyout and those favoring a long-term hold, discussions are heavily focused on the company's ability to maintain its market lead amidst expanding competition.

We’re building an innovative AI agent launchpad tailored for capital managers and crypto researchers. Our platform empowers you to contribute and discover valuable financial insights, create highly customized AI agents powered by your high-quality research, and track their performance with precision. Unlock the potential to optimize decision-making and drive success by leveraging advanced tools and real-time data analysis. Collaborate with a network of like-minded professionals, share insights, and refine strategies to stay ahead in the rapidly evolving world of finance. Whether you're exploring crypto opportunities or managing capital, our launchpad provides the resources to transform your expertise into actionable intelligence.

Rhun Capital

Investors are closely tracking RHUN for its clean price structure and steady consolidation, highlighting the token as a development-stage asset with emerging utility. Community sentiment remains bullish as market participants emphasize the asset's disciplined trading action and its recent expansion across major crypto wallets and exchange platforms.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

MULL is seeing heavy trading activity as investors leverage it as a high-volatility vehicle to play the price action of Micron, with many users actively scalping the swings or accumulating shares on dips. The community is fiercely debating the stock's future potential, with bulls citing technical strength and upward momentum while others warn about the risks of volatility decay inherent in leveraged ETFs.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

Sharplink Gaming is facing intense investor skepticism and volatility as stakeholders scrutinize the company's aggressive Ethereum-focused treasury strategy amid a prolonged, multi-month price decline. While some in the community advocate for a long-term holding strategy citing the accumulation of staked assets and potential institutional adoption, many others are expressing deep frustration over sustained losses and lack of clear performance milestones.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is currently trending as the community actively discusses upcoming major ecosystem announcements, an anticipated partnership at the XRP Las Vegas conference, and the significance of hitting 100,000 holders. While sentiment remains divided between hopeful long-term investors focused on utility and adoption and skeptics who characterize the price action as a pump-and-dump scheme, the primary focus is on the final token unlock and its potential impact on price volatility.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is trending as investors react to M&A speculation surrounding competitors in the KRAS oncology space, while community members actively debate the stock's valuation gap relative to peers despite recent revenue growth and clinical progress. Sentiment remains polarized, with many stakeholders expressing intense frustration over downward price volatility and perceived lack of management transparency, even as others emphasize the long-term potential of the company's dual on/off inhibitor, VS-7375.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is seeing active community discussion around its structural support levels near $150, with investors debating whether the stock represents a defensive value opportunity or a potential falling knife. Traders are closely monitoring the company's dividend reliability and operational efficiency plans while analyzing institutional sentiment ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co.

Congress Asset Management Co. purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure...

TG Therapeutics Procures Additional $500 Mln Funding From Blue Owl Capital

(RTTNews) - TG Therapeutics, Inc. (TGTX), a commercial stage biopharmaceutical company, Thursday announced that it has obtained a new five-year, $750 million senior secured credit facility with funds...

Penn Capital Management Company LLC Grows Stock Position in TG Therapeutics, Inc. $TGTX

Penn Capital Management Company LLC boosted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 17.6% during the third quarter, according to the company in its most recent filing...

TG Therapeutics (NASDAQ:TGTX) Shares Up 7.9% - Here's What Happened

TG Therapeutics (NASDAQ:TGTX) Trading 7.9% Higher - Time to Buy...

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop

Key PointsACT Capital Management added 268,875 shares of TG Therapeutics in the fourth quarter...

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need...

TG Therapeutics, Inc. $TGTX Stake Cut by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky decreased its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 47.5% in the 3rd quarter, according to the company in its...

TG Therapeutics Q4 EPS Forecast Lowered by HC Wainwright

TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright dropped their Q4 2026 earnings estimates for shares of TG Therapeutics in a research note issued to investors on...

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis

HC Wainwright Raises Earnings Estimates for TG Therapeutics

TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at HC Wainwright raised their FY2026 earnings per share estimates for TG Therapeutics in a research report issued to clients and...

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

TGTX
TG Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TGTX News

TGTXTG Therapeutics Inc